Inclusion Criteria:
- English- or Spanish-speaking
- 18 years or older
- Prior cancer diagnosis of any type or stage
- Free of oncological disease, or stable disease with no evidence of progression
- Score of ≥8 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS)
- Report anxiety symptoms lasting at least one month
- Willing to adhere to all study-related procedures, including randomization to one of two treatment arms: MT or CBT
- Access to Zoom and a quiet/private location
Inclusion Criteria for Advanced Cancer Sub-Study (N=50)
- English-speaking
- 18 years or older
- Advanced cancer diagnosis: stage III or IV lung cancer; any stage pancreatic cancer, unresectable cholangiocarcinoma, unresectable liver cancer, unresectable ampullary or peri-ampullary cancer, or other stage IV gastrointestinal cancer; stage III or IV ovarian or fallopian tube cancers or other stage IV gynecologic cancer; stage IV breast cancer; stage III testicular cancer or any stage IV genitourinary cancer; stage IV sarcoma; stage IV melanoma; stage IV endocrine cancer; lymphoma, myeloma, or leukemia
- Currently receiving oncological treatment or on active surveillance
- Karnofsky performance score of ≥60
- Score of ≥8 on the HADS anxiety subscale
- Anxiety symptoms lasting for at least 1 month
- Greater than 6-month expected survival as judged by the treating oncologist
- Willing to adhere to all study procedures
- Access to Zoom and a quiet/private location
Inclusion Criteria for group MT sub-study (N=18)
- English-speaking
- 18 years or older
- Prior cancer diagnosis of any type or stage
- Free of oncological disease, or stable disease with no evidence of progression
- Score of ≥8 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS)
- Report anxiety symptoms lasting at least one month
- Willing to adhere to all study-related procedures
- Access to Zoom and a quiet/private location
Exclusion Criteria:
- Completed active cancer treatment (e.g., surgery, radiation, chemotherapy) less than one month prior to enrollment (maintenance hormonal or targeted therapies are allowed).
- Active suicidal ideation, bipolar disorder, schizophrenia, or substance abuse
- Score of ≥10 indicative of cognitive impairment on the Blessed Orientation-Memory-Concentration
- Received a treatment course of seven or greater MT or CBT sessions for anxiety symptoms within the last six months
- Unable to provide informed consent for themselves
Exclusion Criteria for Advanced Cancer Sub-Study
- Active suicidal ideation; bipolar disorder, schizophrenia, or substance abuse
- Score of ≥10 on Blessed Orientation-Memory-Concentration
- Prior receipt of MT within the past six months
- Plan to receive any form of psychotherapy in the coming 8 weeks
- Initiation or change in anxiety medications within the past 4 weeks
- Plan to initiate or change anxiety medications in the coming 8 weeks
- Unable to provide informed consent for themselves
Exclusion Criteria for group MT sub-study
- Completed active cancer treatment (e.g., surgery, radiation, chemotherapy) less than one month prior to enrollment (maintenance hormonal or targeted therapies are allowed).
- Active suicidal ideation; bipolar disorder, schizophrenia, or substance abuse
- Score of ≥10 on Blessed Orientation-Memory-Concentration
- Prior receipt of MT within the past six months
- Plan to receive any form of psychotherapy in the coming 8 weeks
- Initiation or change in anxiety medications within the past 4 weeks
- Unable to provide informed consent for themselves